Search research articles
Contact Us
Filters
Showing results (171-180 of 436) with videos related to
Page
of 44
Sort By:
Blood Reviews
|
September 1, 1994
The role of fludarabine in hematological malignancies
S J Wright, L E Robertson, S O'Brien, et al.
Leukemia
|
May 21, 2016
Decrease in total protein level of Bruton's tyrosine kinase during ibrutinib therapy in chronic lymphocytic leukemia lymphocytes
F Cervantes-Gomez, V Kumar Patel, P Bose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1995
Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia
V Gandhi, E Estey, M Du, et al.
Leukemia
|
November 1, 1992
New drugs in the treatment of chronic lymphocytic leukemia
M J Keating, S O'Brien, L Robertson, et al.
Cancer Research
|
November 1, 1990
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia
R Grunewald, H Kantarjian, M J Keating, et al.
British Journal of Haematology
|
October 29, 2000
Allogeneic haematopoietic transplantation for Richter's syndrome
J Rodriguez, M J Keating, S O'Brien, et al.
Leukemia
|
March 1, 1996
Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome
L E Robertson, W Plunkett, K McConnell, et al.
Leukemia & Lymphoma
|
January 1, 1993
Treatment of relapsed or refractory AML with intermediate-dose arabinosylcytosine (ara-C): confirmation of the importance of ara-C triphosphate formation in mediating response to ara-C
E H Estey, W Plunkett, H Kantarjian, et al.
Seminars in Oncology
|
June 1, 1987
Continuous infusion high-dose cytosine arabinoside without anthracyclines as induction and intensification therapy in adults under age 50 with newly diagnosed acute myelogenous leukemia
E Estey, M J Keating, W Plunkett, et al.
Cancer
|
January 15, 1981
Antibody responses of remission leukemia patients receiving active specific and nonspecific immunotherapy
C H Granatek, K Ezaki, E M Hersh, et al.
Page
of 44
Search research articles
Search
Showing results (171-180 of 436) with videos related to
Sort By:
Page
of 44
Blood Reviews
|
September 1, 1994
The role of fludarabine in hematological malignancies
S J Wright, L E Robertson, S O'Brien, et al.
Leukemia
|
May 21, 2016
Decrease in total protein level of Bruton's tyrosine kinase during ibrutinib therapy in chronic lymphocytic leukemia lymphocytes
F Cervantes-Gomez, V Kumar Patel, P Bose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1995
Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia
V Gandhi, E Estey, M Du, et al.
Leukemia
|
November 1, 1992
New drugs in the treatment of chronic lymphocytic leukemia
M J Keating, S O'Brien, L Robertson, et al.
Cancer Research
|
November 1, 1990
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia
R Grunewald, H Kantarjian, M J Keating, et al.
British Journal of Haematology
|
October 29, 2000
Allogeneic haematopoietic transplantation for Richter's syndrome
J Rodriguez, M J Keating, S O'Brien, et al.
Leukemia
|
March 1, 1996
Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome
L E Robertson, W Plunkett, K McConnell, et al.
Leukemia & Lymphoma
|
January 1, 1993
Treatment of relapsed or refractory AML with intermediate-dose arabinosylcytosine (ara-C): confirmation of the importance of ara-C triphosphate formation in mediating response to ara-C
E H Estey, W Plunkett, H Kantarjian, et al.
Seminars in Oncology
|
June 1, 1987
Continuous infusion high-dose cytosine arabinoside without anthracyclines as induction and intensification therapy in adults under age 50 with newly diagnosed acute myelogenous leukemia
E Estey, M J Keating, W Plunkett, et al.
Cancer
|
January 15, 1981
Antibody responses of remission leukemia patients receiving active specific and nonspecific immunotherapy
C H Granatek, K Ezaki, E M Hersh, et al.
Page
of 44